8.2 Compartmental Models and Pharmacokinetics

Compartmental models provide a mathematical framework for describing how drugs distribute through and get eliminated from the body. By dividing the body into hypothetical "compartments," these models let you predict drug concentrations over time, which is essential for designing safe and effective dosing regimens.

In both biomedical research and clinical practice, compartmental models help predict drug levels, design clinical trials, and personalize doses for individual patients.

Compartmental Modeling Concepts

Fundamentals of Compartmental Modeling

Compartmental modeling is a mathematical approach for analyzing how drugs (or other substances) distribute and get eliminated in the body. The body is divided into hypothetical compartments, each representing a group of tissues or organs with similar blood flow and drug distribution characteristics.

• The central compartment typically represents blood and highly perfused organs (heart, lungs, liver, kidneys)
• Peripheral compartments represent tissues with lower blood flow or slower drug uptake (muscle, fat, skin)

Two key assumptions underlie these models:

1. Drug distribution within each compartment is instantaneous and homogeneous, meaning concentration is uniform throughout the compartment at any given time.
2. Drug transfer between compartments follows first-order kinetics, where the rate of transfer is proportional to the drug concentration in the source compartment.

These are simplifications, but they make the math tractable while still capturing the dominant behavior of most drugs.

Factors Influencing Drug Distribution and Transfer

The rate of drug transfer between compartments is governed by rate constants, which depend on several physiological and chemical factors:

• Blood flow to the tissue or organ
• Tissue permeability and the drug's ability to cross cell membranes
• Protein binding, both to plasma proteins and tissue components
• Physicochemical properties of the drug, including lipophilicity (how fat-soluble it is), molecular size, and ionization state

The number of compartments you choose depends on how complex the drug's distribution behavior is. Simple drugs may only need one or two compartments, while drugs with extensive tissue binding or multiple elimination routes may require three or more.

Compartmental Models for Drug Kinetics

Types of Compartmental Models

One-compartment models treat the body as a single, well-mixed compartment. Drug elimination occurs directly from this central compartment. These work well for drugs that distribute rapidly and have straightforward elimination profiles, such as aspirin or ethanol.

Two-compartment models add a peripheral compartment to account for drug redistribution between highly perfused tissues (central) and more slowly perfused tissues like muscle or fat. Drugs like gentamicin and theophylline, which show a distinct distribution phase before reaching equilibrium, are often modeled this way.

Three-compartment models split the peripheral space into two separate compartments representing tissues with different distribution rates. For instance, one peripheral compartment might represent muscle while another represents bone or brain tissue. Drugs like methotrexate and digoxin, which have extensive tissue binding or multiple elimination pathways, may require this level of detail.

Developing and Solving Compartmental Models

Building a compartmental model involves writing differential equations that describe how drug concentration changes in each compartment over time. These equations use rate constants for transfer between compartments ($k_{12}$, $k_{21}$, $k_{13}$, $k_{31}$) and for elimination from the body ($k_{10}$).

For a two-compartment model, the governing equations are:

$\frac{dC_1}{dt} = k_{21}C_2 - (k_{12} + k_{10})C_1$

$\frac{dC_2}{dt} = k_{12}C_1 - k_{21}C_2$

Here, $C_1$ is the drug concentration in the central compartment and $C_2$ is the concentration in the peripheral compartment. The first equation says: drug flows in from the peripheral compartment ($k_{21}C_2$) and flows out via transfer to the peripheral compartment and elimination ($k_{12} + k_{10}$).

Solving these equations typically involves three steps:

1. Apply Laplace transforms to convert the system of differential equations from the time domain into the $s$-domain, where they become algebraic equations.
2. Manipulate the algebraic equations to isolate the concentration terms.
3. Apply the inverse Laplace transform to obtain concentration as a function of time.

Once you have the analytical solution, model parameters (rate constants, volume of distribution) are estimated by fitting the model to experimental data using nonlinear regression. This minimizes the difference between predicted and observed drug concentrations at measured time points.

Pharmacokinetic Principles for Dosing

ADME Processes and Their Impact on Drug Kinetics

The four processes that govern a drug's journey through the body are collectively called ADME: Absorption, Distribution, Metabolism, and Excretion. Each can be incorporated into compartmental models.

Absorption describes how a drug enters systemic circulation from its administration site.

• First-order absorption: the rate of absorption is proportional to the amount of drug remaining to be absorbed. This is typical for oral tablets and capsules.
• Zero-order absorption: the rate of absorption is constant over time. This applies to IV infusions and controlled-release formulations.

Distribution is the reversible transfer of drug between blood and tissues. The volume of distribution ($V_d$) quantifies the extent of distribution by relating the total amount of drug in the body to the measured plasma concentration. A large $V_d$ means the drug distributes extensively into tissues; a small $V_d$ means it stays mostly in the blood.

Metabolism is the biochemical transformation of a drug into metabolites, which may have different pharmacological activity and elimination rates. In a compartmental model, metabolism can appear as an additional elimination pathway or as a separate compartment for the metabolite.

Excretion is the removal of drug or metabolites from the body, primarily through the kidneys or bile. The rate of excretion is described by clearance ($CL$), which represents the volume of plasma completely cleared of drug per unit time.

Predicting Drug Concentrations and Optimizing Dosing Regimens

Compartmental models predict drug concentrations over time based on the dose, route of administration, and patient-specific parameters. These predictions directly inform dosing decisions.

Three key dosing concepts:

• Loading dose: an initial higher dose given to rapidly reach therapeutic concentrations, rather than waiting for repeated smaller doses to accumulate.
• Maintenance dose: the recurring dose that keeps the drug at steady-state concentrations.
• Dosing interval: the time between consecutive doses, determined primarily by the drug's half-life and the acceptable range of peak-to-trough concentrations.

For example, a two-compartment model can predict the peak and trough concentrations of an antibiotic given by intermittent IV infusion, helping clinicians verify that peak levels are high enough to be effective while trough levels stay low enough to avoid toxicity.

These models also allow you to simulate what happens when you change dosing regimens or patient parameters. This is how doses get individualized based on factors like age, weight, renal function, or genetic variations in drug-metabolizing enzymes.

Limitations and Applications of Compartmental Models

Limitations and Assumptions

Compartmental models are simplifications, and their assumptions don't always hold:

• The "well-mixed compartment" assumption may break down for drugs with slow or highly variable distribution kinetics.
• Instantaneous equilibrium within a compartment isn't realistic for every drug or physiological condition.
• Prediction accuracy depends heavily on the quality and quantity of experimental data used for parameter estimation. Sparse or noisy data lead to poor parameter estimates.
• The choice of model structure (how many compartments, which processes to include) directly affects how well the model describes observed data.

Compartmental models also struggle with nonlinear pharmacokinetics, such as saturable metabolism or active transport. When enzyme systems become saturated (as with high-dose phenytoin, for example), elimination no longer follows first-order kinetics. In these cases, more sophisticated approaches are needed, such as physiologically based pharmacokinetic (PBPK) models or nonlinear mixed-effects models.

Applications in Research and Clinical Practice

Despite these limitations, compartmental models are widely used across biomedical engineering and medicine:

• Individualized dosing: Models guide dose adjustments for drugs with narrow therapeutic indices (aminoglycosides, antiepileptics), especially in patients with impaired renal or hepatic function.
• Clinical study design: Models help determine optimal blood sampling times and the number of subjects needed to estimate pharmacokinetic parameters with sufficient precision. They also help identify sources of variability in drug exposure between subjects.
• Drug development: In preclinical and clinical stages, models guide dose selection, predict drug-drug interactions, and help extrapolate pharmacokinetic data from animal studies to humans. They can also simulate how changes in formulation or administration route affect drug exposure.
• PK/PD modeling: Compartmental models can be extended to link drug concentrations with therapeutic effects. These pharmacokinetic-pharmacodynamic (PK/PD) models describe the time course of drug action, identify concentration-response relationships, and optimize dosing based on therapeutic targets. PK/PD models have been particularly valuable in antimicrobial development, where the relationship between drug exposure and bacterial killing determines effective dosing strategies.